市場調査レポート

商品コード

1800880

髄膜炎菌ワクチン市場レポート：ワクチンタイプ、組成、ワクチン血清型、流通チャネル、エンドユーザー、地域別、2025年～2033年

Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 445,531円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 594,091円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 742,651円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.56円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の髄膜炎菌ワクチン市場規模は2024年に39億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに76億米ドルに達し、2025年から2033年にかけて7.3%の成長率（CAGR）を示すと予測しています。髄膜炎菌感染症の負担の増加、政府の予防接種プログラム、継続的な技術の進歩、世界の健康安全保障への懸念が、主に市場成長の原動力となっています。

髄膜炎菌ワクチン市場動向：

髄膜炎菌性疾患の有病率の上昇

髄膜炎菌性疾患の有病率の上昇は、髄膜炎菌ワクチンの需要を促進する重要な要因です。例えば、世界保健機関（WHO）によると、2022年11月から2023年1月にかけて、ニジェール南東部のジンダー地方では、2021年11月から2022年1月にかけて報告された231件と比較して、18人の死亡を含む約559件の髄膜炎が記録されました。髄膜炎菌感染症は髄膜炎菌によって引き起こされ、急速な発症、重症化、集団発生の可能性があるため、依然として世界の健康上の重大な懸念となっています。高い疾病負担が、効果的なワクチンの需要を促進しています。これらの要因が、今後数年間における髄膜炎菌ワクチン市場の推進力になると予想されます。

啓発プログラムの増加

公衆衛生キャンペーン、ヘルスケアプロバイダーによる教育、地域社会への働きかけにより、髄膜炎菌感染症やワクチン接種の重要性に関する認識が高まっています。例えば、2021年8月、GSKは「Ask2BSure」という公衆衛生キャンペーンを実施し、親が髄膜炎菌Bの予防接種を受けているかどうかを子どものかかりつけ医に確認するよう促しました。髄膜炎菌性疾患は髄膜炎として知られることが多く、まれではあるが致命的な疾患である可能性があります。理解を深めることで、ワクチンの受容と摂取が促進されます。これらの要因は、髄膜炎菌ワクチン市場予測にさらにプラスの影響を与えます。

政府の予防接種プログラム

多くの国では、乳幼児、青少年、ハイリスクグループを対象に、髄膜炎菌ワクチンを含む定期予防接種スケジュールを策定しています。例えば、西オーストラリア州政府保健局の2022年11月の更新によると、学校ベースの予防接種プログラム（SBIP）は、2023年からジフテリア破傷風百日咳（dTpa）、HPV（ヒトパピローマウイルス）、髄膜炎菌ACWYワクチンを生徒に提供します。同様に、2023年8月、クイーンズランド州政府は、今後3年間で9,000万米ドルを投資し、幼児と成人を対象に髄膜炎菌Bワクチンの無料接種を実施する予定であり、髄膜炎菌ワクチンシステム市場の収益を押し上げることになります。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第12章 SWOT分析

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第15章価格分析

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- GlaxoSmithKline Plc
- Hualan Biological Engineering Inc.
- Incepta Pharmaceuticals Limited
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Serum Institute of India Ltd.
- Walvax Biotechnology Co. Ltd.

図表

List of Figures

Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2024
Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2024
Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2024
Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2024
Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2024
Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
Figure 94: Global: Meningococcal Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million USD), 2025-2033
Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million USD), 2025-2033
Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
Table 9: Global: Meningococcal Vaccines Market: Key Players

Product Code: SR112025A2730

The global meningococcal vaccines market size reached USD 3.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.3% during 2025-2033. The increasing burden of meningococcal disease, government immunization programs, ongoing technological advancements, and global health security concerns are driving the primarily driving the market growth.

Meningococcal Vaccines Market Trends:

Rising Prevalence of Meningococcal Disease

The rising prevalence of meningococcal disease is a significant factor driving the demand for meningococcal vaccines. For instance, according to the World Health Organization (WHO), from November 2022 to January 2023, around 559 cases of meningitis, including 18 deaths, were recorded from Zinder Region, southeast of Niger, compared to 231 cases reported from November 2021 to January 2022. Meningococcal disease, caused by Neisseria meningitidis bacteria, remains a significant global health concern due to its potential for rapid onset, severity, and outbreaks. The high disease burden drives the demand for effective vaccines. These factors are expected to propel the meningococcal vaccines market in the coming years.

Increasing Awareness Programs

Public health campaigns, healthcare provider education, and community outreach efforts have increased awareness about meningococcal disease and the importance of vaccination. For instance, in August 2021, GSK introduced "Ask2BSure," a public health campaign to encourage parents to check with their child's doctor to see if they have meningitis B immunization. Meningococcal disease, often known as meningitis, is a rare but potentially fatal condition. Enhanced understanding promotes vaccine acceptance and uptake. These factors further positively influence the meningococcal vaccines market forecast.

Government Immunization Programs

Many countries have established routine immunization schedules that include meningococcal vaccines, targeting infants, adolescents, and high-risk groups. For example, according to a November 2022 update from the Government of Western Australia Department of Health, the School-Based Immunization Program (SBIP) would provide Diphtheria-tetanus-pertussis (dTpa), HPV (human papillomavirus), and Meningococcal ACWY vaccines to students beginning 2023. Similarly, in August 2023, the Queensland Government planned to invest US$ 90 million over the next three years to offer free meningococcal B vaccine vaccinations for young children and adults, thereby boosting the meningococcal vaccine systems market revenue.

Global Meningococcal Vaccines Industry Segmentation:

Breakup by Vaccine Type:

Conjugate
Polysaccharide
Subcapsular

According to the meningococcal vaccines market outlook, conjugate vaccines are composed of polysaccharide antigens from the bacterial capsule of Neisseria meningitidis, chemically linked (conjugated) to a carrier protein. While polysaccharide vaccines contain purified polysaccharide antigens derived from the bacterial capsule of Neisseria meningitidis. Moreover, subcapsular vaccines target specific surface proteins or antigens located within the bacterial capsule or outer membrane of Neisseria meningitidis.

Breakup by Composition:

Mono Vaccines
Combination Vaccines

According to the meningococcal vaccines market overview, monovalent vaccines are often in demand during outbreaks or localized epidemics caused by specific meningococcal serogroup. Public health authorities may deploy monovalent vaccines to quickly contain outbreaks and prevent further spread of the disease. While combination vaccines that protect against multiple meningococcal serogroups (e.g., MenACWY) are favored for routine immunization schedules. They streamline vaccination programs by reducing the number of injections and clinic visits required to achieve comprehensive protection.

Breakup by Vaccine Serotype:

MenACWY
MenB & Manic
MenC
MenA
MenAC
Others

MenACWY vaccines protect against meningococcal serogroups A, C, W, and Y. While MenB vaccines target meningococcal serogroup B. MenB vaccines are typically recombinant protein-based or outer membrane vesicle (OMV) vaccines. They contain antigens specific to serogroup B, which are distinct in structure from serogroups A, C, W, and Y. Moreover, MenAC vaccines target meningococcal serogroups A and C. Apart from this, MenA vaccines specifically target meningococcal serogroup A. These are typically monovalent vaccines containing polysaccharide antigens from serogroup A Neisseria meningitidis. Furthermore, MenACWY-DT vaccines combine antigens from meningococcal serogroups A, C, W, and Y.

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others

Hospitals often administer meningococcal vaccines to patients admitted for various reasons, including those at higher risk of contracting meningococcal disease due to immunocompromised status or underlying conditions. Hospital pharmacies may provide vaccinations to individuals requiring preventive care or as part of travel medicine services. While retail pharmacies cater to the general public, offering convenient access to meningococcal vaccines for individuals seeking preventive healthcare. Apart from this, institutional sales involve large-scale procurement of meningococcal vaccines for public health programs, such as national immunization schedules targeting specific age groups or high-risk populations.

Breakup by End User:

Pediatric
Adult

Meningococcal vaccines, such as MenACWY, are included in routine childhood immunization schedules in many countries. Vaccination typically begins in infancy and continues through childhood, with doses administered according to national guidelines. While young adults who missed meningococcal vaccination during adolescence may receive catch-up doses, especially before entering college or university. College and university dormitories often require proof of meningococcal vaccination, boosting demand among this age group.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the meningococcal vaccines market statistics, the rising prevalence of meningococcal disease in North America is a primary driver. Meningococcal infections can lead to severe outcomes, including meningitis and sepsis, which have spurred vaccination efforts. While stringent healthcare policies and regulations in Europe support the adoption and inclusion of meningococcal vaccines in national immunization schedules. This regulatory environment provides stability and encourages vaccine development and distribution. Apart from this, the Asia Pacific region has seen an increase in the incidence of meningococcal disease, prompting higher demand for vaccines.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

GlaxoSmithKline Plc
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Limited
Novartis AG
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Ltd.
Walvax Biotechnology Co. Ltd.

Key Questions Answered in This Report

How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global meningococcal vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the composition?
What is the breakup of the market based on the vaccine serotype?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global meningococcal vaccines market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Meningococcal Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Vaccine Type

6.1 Conjugate
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Polysaccharide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Subcapsular
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Composition

7.1 Mono Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Combination Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Vaccine Serotype

8.1 MenACWY
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 MenB & Manic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 MenC
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 MenA
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 MenAC
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Institutional Sales
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by End User

10.1 Pediatric
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Adult
- 10.2.1 Market Trends
- 10.2.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 GlaxoSmithKline Plc
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Hualan Biological Engineering Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
- 16.3.3 Incepta Pharmaceuticals Limited
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Novartis AG
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Pfizer Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 Sanofi S.A.
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 Financials
  - 16.3.6.4 SWOT Analysis
- 16.3.7 Serum Institute of India Ltd.
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 Walvax Biotechnology Co. Ltd.
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials

髄膜炎菌ワクチン市場レポート：ワクチンタイプ、組成、ワクチン血清型、流通チャネル、エンドユーザー、地域別、2025年～2033年

Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2025-2033

髄膜炎菌ワクチン市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の髄膜炎菌ワクチン市場

第6章 市場内訳：ワクチンタイプ別

第7章 市場内訳：組成別

第8章 市場内訳：ワクチン血清型別

第9章 市場内訳：流通チャネル別

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

第16章 競合情勢